Evaluation of risk factors for 14-day and 30-day mortality among treatment regimens against Pseudomonas aeruginosa resistant to carbapenem but susceptible to traditional antipseudomonal non-carbapenem β-lactam agents
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0313944 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Suvadee Supreeyasakon und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacotherapy Thailand, Nonthaburi, Thailand. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Carbapenems, Pseudomonas Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Silpakorn University.
Abstract (Originalsprache)
Pseudomonas aeruginosa associated with hospital-acquired infection is often resistant to various antibiotics and is associated with high mortality worldwide. The appropriate treatment of Pseudomonas aeruginosa resistant to carbapenems but susceptible to traditional antipseudomonal non-carbapenem β-lactam agents (Car-R/NonCar-S P . aeruginosa ) remains unclear. This retrospective study evaluated risk factors for 14-day and 30-day mortality among treatment regimens against Car-R/NonCar-S P . aeruginosa . This study enrolled 180 patients with Car-R/NonCar-S P . aeruginosa infection at Phramongkutklao Hospital between January 2019 and December 2023. The 14-day and 30-day mortality rates were 18.3% and 28.9%, respectively. Bloodstream infection (OR 1.97, 95% CI 0.88–4.43), septic shock (OR 3.3, 95% CI 1.30–8.40), Acute Physiology and Chronic Health Evaluation (APACHE) II < 14 (OR 0.13, 95% CI 0.03–0.54), Sequential Organ Failure Assessment (SOFA)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmacotherapy Thailand, Nonthaburi, Thailand.
- Department of Pharmaceutical Care, Faculty of Pharmacy, Huachiew Chalermprakiet University, Samut Prakan, Thailand.
- Division of Infectious Diseases, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
- Department of Pharmaceutical Care, Faculty of Pharmacy, Silpakorn University, Nakorn Pathom, Thailand.
- Division of Microbiology, Phramongkutklao Hospital, Bangkok, Thailand.
- Pharmaceutical Initiative for Resistant Bacteria and Infectious Disease Working Group (PIRBIG), Nakorn Pathom, Thailand.
ORCID-Profile: Suvadee Supreeyasakon, Jatapat Hemapanpairoa, Wichai Santimaleeworagun
Förderung
- Silpakorn University
Zitieren
APA
Supreeyasakon, S., Traipattanakul, J., Hemapanpairoa, J., Juntanawiwat, P., & Santimaleeworagun, W. (2024). Evaluation of risk factors for 14-day and 30-day mortality among treatment regimens against Pseudomonas aeruginosa resistant to carbapenem but susceptible to traditional antipseudomonal non-carbapenem β-lactam agents. PLOS ONE. https://doi.org/10.1371/journal.pone.0313944
Vancouver
Supreeyasakon S, Traipattanakul J, Hemapanpairoa J, Juntanawiwat P, Santimaleeworagun W. Evaluation of risk factors for 14-day and 30-day mortality among treatment regimens against Pseudomonas aeruginosa resistant to carbapenem but susceptible to traditional antipseudomonal non-carbapenem β-lactam agents. PLOS ONE. 2024. doi:10.1371/journal.pone.0313944
BibTeX
@article{Supreeyasakon2024,
author = {Supreeyasakon, Suvadee and Traipattanakul, Jantima and Hemapanpairoa, Jatapat and Juntanawiwat, Piraporn and Santimaleeworagun, Wichai},
title = {Evaluation of risk factors for 14-day and 30-day mortality among treatment regimens against Pseudomonas aeruginosa resistant to carbapenem but susceptible to traditional antipseudomonal non-carbapenem β-lactam agents},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0313944}
}
EUVIMED